{"id":56360,"date":"2025-11-24T08:08:19","date_gmt":"2025-11-24T12:08:19","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/european-leaders-advance-ukraine-peace-talks-eye-russian-assets-novo-nordisk-plummets-on-alzheimers-trial-results\/56360\/"},"modified":"2025-11-24T08:08:19","modified_gmt":"2025-11-24T12:08:19","slug":"european-leaders-advance-ukraine-peace-talks-eye-russian-assets-novo-nordisk-plummets-on-alzheimers-trial-results","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/european-leaders-advance-ukraine-peace-talks-eye-russian-assets-novo-nordisk-plummets-on-alzheimers-trial-results\/56360\/","title":{"rendered":"European Leaders Advance Ukraine Peace Talks, Eye Russian Assets; Novo Nordisk Plummets on Alzheimer&#8217;s Trial Results"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) shares plunged 12%<\/strong> after its EVOKE Phase 3 trials for semaglutide in Alzheimer&#39;s disease failed to demonstrate a statistically significant reduction in disease progression.<\/li>\n<li>European leaders, including <strong>German Chancellor Merz, Polish Prime Minister Tusk, and EU Commission President von der Leyen<\/strong>, signaled renewed momentum in Ukraine peace talks, emphasizing the need for a strong Ukrainian army and solid security guarantees.<\/li>\n<li><strong>Polish PM Tusk<\/strong> indicated that the European Union is nearing a decision on utilizing frozen Russian assets to fund Ukraine&#39;s reconstruction efforts.<\/li>\n<li><strong>US Commerce Secretary Lutnick<\/strong> detailed ongoing US-EU trade discussions, noting the EU&#39;s interest in changes to steel regulations and the US&#39;s focus on digital rules and big tech.<\/li>\n<li>A proposed generational smoking ban in Northern Ireland is reportedly facing <strong>EU pushback<\/strong> from member states like Greece, Slovakia, and Romania, citing potential breaches of single market principles.<\/li>\n<\/ul>\n<p>European leaders convened today, expressing a unified stance on Ukraine&#39;s future and progress in peace negotiations, while a major pharmaceutical company faced a significant setback in its Alzheimer&#39;s research. Meanwhile, US and EU officials continued discussions on critical trade matters, and a proposed smoking ban sparked controversy.<\/p>\n<h3>Ukraine&#39;s Path Forward: Peace Talks and Frozen Assets<\/h3>\n<p>There is &quot;new momentum&quot; on Ukraine peace talks, with &quot;significant progress&quot; reported, according to EU&#39;s Costa. German Chancellor Merz reiterated that Ukraine requires a <strong>strong army<\/strong> and <strong>solid security guarantees<\/strong>, asserting that Ukraine cannot be compelled to surrender territory. Merz also stressed that any peace plan for Ukraine must have <strong>European backing<\/strong> and that peace cannot be achieved overnight.<\/p>\n<p>EU Commission President Ursula von der Leyen reaffirmed that Ukraine&#39;s <strong>territory and sovereignty must be respected<\/strong>, and that only Ukraine can make decisions regarding its forces and destiny. Polish Prime Minister Donald Tusk indicated that the EU is &quot;closer to a decision&quot; that would allow frozen Russian funds to be used for Ukraine&#39;s reconstruction. This development marks a potential breakthrough in funding the war-torn nation&#39;s rebuilding efforts.<\/p>\n<h3>Novo Nordisk&#39;s Alzheimer&#39;s Setback<\/h3>\n<p>Pharmaceutical giant Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) saw its shares <strong>fall by 12%<\/strong> after announcing disappointing results from its EVOKE Phase 3 trials for semaglutide in Alzheimer&#39;s disease. The trials did not confirm the superiority of semaglutide over placebo in reducing the progression of Alzheimer&#39;s disease, nor did they demonstrate a statistically significant reduction in disease progression.<\/p>\n<p>While semaglutide improved biomarkers, it did not delay disease progression. Consequently, the one-year extension period in the EVOKE and EVOKE+ trials will be discontinued based on the observed efficacy results. The full results are slated for presentation at the CTAD conference on December 3, 2025.<\/p>\n<h3>US-EU Trade Discussions and Chip Security<\/h3>\n<p>US Commerce Secretary Lutnick provided insights into ongoing trade negotiations between the US and the EU. Lutnick noted that the EU is seeking changes in the area of <strong>steel regulations<\/strong>, while the US is focused on <strong>digital rules<\/strong>. These discussions also encompass rules on <strong>Big Tech<\/strong>.<\/p>\n<p>Lutnick expressed confidence that &quot;best&quot; US chips would not fall into the &quot;wrong hands&quot; and suggested that a recent chips deal with Saudi Arabia could serve as a model for other agreements. He also mentioned that talks with China would &quot;work their way through&quot; and that the US is actively seeking to enhance the US-EU deal.<\/p>\n<h3>EU Pushback on Northern Ireland Smoking Ban<\/h3>\n<p>In a separate development, Starmer&#39;s proposed generational smoking ban in Northern Ireland is reportedly facing pushback from several EU member states. Greece, Slovakia, and Romania are among the countries suggesting that the ban breaches <strong>Single Market principles<\/strong>. This indicates potential friction between the UK&#39;s internal policies and broader EU trade regulations.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novo Nordisk (NVO) shares plunged 12% after its EVOKE Phase 3 trials for semaglutide in Alzheimer&#39;s disease failed [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[7948,3744,9330,10576,5039,11564,5042,14942,6042,14943,6209,6334,6543,6946,6947],"class_list":["post-56360","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-semaglutide","tag-nvo","tag-alzheimers","tag-lutnick","tag-eu","tag-frozen-assets","tag-ukraine","tag-digital-rules","tag-steel","tag-tusk","tag-peace-talks","tag-novo-nordisk","tag-us-eu-trade","tag-merz","tag-von-der-leyen"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/56360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=56360"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/56360\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=56360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=56360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=56360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}